TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients

[Clinical research on the treatment effect of autologous dendritic cell vaccine on the patients with chronic hepatitis B]

Dendritic cell-based immunotherapy for the treatment of hematological malignancies